Outside the Lab

 Outside the Lab Public health

Accessing Big Pharma's Conscience

| Jayasree K. Iyer

Jayasree K. Iyer, Executive Director of Access to Medicine Foundation, the Netherlands
Outside the Lab Professional development

Speed Versus Safety for Cell Therapy

| Karen Nichols and Jacques Galipeau

We want faster translation of cell therapies, but is it worth sacrificing public trust?
Outside the Lab Drug discovery

Taking Cues from the City of Notions

| Chas Bountra

Boston leads the drug discovery field, and the UK could soon follow suit
Outside the Lab Immunology

Cold War

| James Strachan

A vaccine against the common cold has long eluded us, but now researchers are on its track
Outside the Lab Cancer

A Personnel Story

| Rasha Kelej

The human element is key to tackle rising cancer rates in Africa
Outside the Lab Professional development

Diversity, Equity, and Problem-solving

| Kimberly Tanner

Diversity and equity in the biosciences are about more than just "being nice"
Outside the Lab Clinical trials

See-Through Science at GSK

| Murray Stewart

Opening up our clinical trial results takes investment, but it's the right thing to do
Outside the Lab Biomedical engineering

The Organ Grower

| Charlotte Barker

Anthony Atala, Director, Wake Forest Institute for Regenerative Medicine
Outside the Lab Clinical trials

The March Towards Trial Transparency

| James Cockerill

Many clinical trial results are never reported, but AllTrials hopes to change that
Outside the Lab Professional development

Human Challenge Trials

| Adrian Wildfire

When biomarkers aren't an option in vaccine research, we need a well-supported alternative
Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register

October Issue of The Translational Scientist